Guangdong Transtek Medical Electronics Co., Ltd (SHE:300562)
China · Delayed Price · Currency is CNY 12.73
-0.43 (-3.27%)
Nov 13, 2026, 3:04 PM CST
SHE:300562 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Cash & Equivalents | 113.72 | 702.59 | 764 | 666.47 | 595.31 | 435.97 |
Trading Asset Securities | 616.72 | 3.15 | 0.19 | 11.2 | 59.54 | 100.53 |
Cash & Short-Term Investments | 730.44 | 705.74 | 764.2 | 677.67 | 654.85 | 536.5 |
Cash Growth | 2.83% | -7.65% | 12.77% | 3.48% | 22.06% | 46.48% |
Accounts Receivable | 160.39 | 167.05 | 160.99 | 216.2 | 183.51 | 403.52 |
Other Receivables | 3.3 | 9.51 | 4.64 | 6.2 | 12.12 | 7.12 |
Receivables | 163.7 | 176.56 | 165.63 | 222.4 | 195.62 | 410.64 |
Inventory | 111.45 | 76.85 | 96.19 | 86.62 | 111.22 | 208.81 |
Other Current Assets | 20.13 | 17.24 | 20.53 | 12.71 | 23.43 | 34.98 |
Total Current Assets | 1,026 | 976.39 | 1,047 | 999.4 | 985.13 | 1,191 |
Property, Plant & Equipment | 216.73 | 222.23 | 236.19 | 247.51 | 267.08 | 318.8 |
Long-Term Investments | 164.09 | 96 | 116.85 | 185.89 | 171.93 | 167.43 |
Goodwill | - | - | 9.05 | 17.59 | 17.59 | 21.03 |
Other Intangible Assets | 50.72 | 56.4 | 62.71 | 66.43 | 78.74 | 69.95 |
Long-Term Deferred Tax Assets | 17.03 | 17.99 | 15.31 | 16.65 | 17.61 | 10.9 |
Long-Term Deferred Charges | 7.98 | 8.48 | 12.18 | 8.6 | 8.23 | 15.46 |
Other Long-Term Assets | 13.05 | 13.88 | 13.92 | 14.42 | 1 | - |
Total Assets | 1,495 | 1,391 | 1,513 | 1,556 | 1,547 | 1,794 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Accounts Payable | 221.91 | 234.96 | 244.28 | 257.2 | 258.64 | 546.3 |
Accrued Expenses | 32.07 | 27.27 | 23.17 | 22.95 | 28.28 | 41.51 |
Short-Term Debt | 37.1 | 47 | 181.69 | 123.78 | 133.11 | 16.62 |
Current Portion of Leases | - | 3.23 | 4.38 | 4.39 | 5.68 | 8.02 |
Current Income Taxes Payable | 6.99 | 1.58 | 1.95 | 0.44 | 0 | 0.01 |
Current Unearned Revenue | 41.28 | 32.37 | 25.42 | 35.61 | 54.54 | 34.56 |
Other Current Liabilities | 30.68 | 26.48 | 36.03 | 45.14 | 21.07 | 64.33 |
Total Current Liabilities | 371.59 | 372.88 | 516.91 | 489.52 | 501.32 | 711.35 |
Long-Term Debt | - | - | 0.19 | - | - | - |
Long-Term Leases | 1.92 | 0.26 | 3.6 | 6.8 | 5.44 | 12.84 |
Long-Term Unearned Revenue | 9.65 | 10.37 | 10.52 | 11.19 | 10.11 | - |
Long-Term Deferred Tax Liabilities | 20.55 | 3.3 | 5.03 | 24.83 | 27.29 | 22.91 |
Other Long-Term Liabilities | 1.55 | 1.55 | - | - | 4.29 | - |
Total Liabilities | 405.26 | 388.36 | 536.25 | 532.35 | 548.46 | 747.1 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Common Stock | 218.57 | 217.75 | 217.47 | 216.9 | 214.7 | 214.48 |
Additional Paid-In Capital | 526.84 | 536.44 | 530.22 | 519.01 | 506.93 | 507.62 |
Retained Earnings | 356.28 | 300.18 | 278.86 | 278.11 | 245.89 | 280.16 |
Treasury Stock | - | - | -13.1 | -10.93 | - | -1.26 |
Comprehensive Income & Other | 10.61 | -29.95 | -17.28 | 37.52 | 44.6 | 53.84 |
Total Common Equity | 1,112 | 1,024 | 996.17 | 1,041 | 1,012 | 1,055 |
Minority Interest | -22.25 | -21.39 | -19.66 | -16.45 | -13.28 | -7.45 |
Shareholders' Equity | 1,090 | 1,003 | 976.51 | 1,024 | 998.85 | 1,047 |
Total Liabilities & Equity | 1,495 | 1,391 | 1,513 | 1,556 | 1,547 | 1,794 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Total Debt | 40.59 | 50.49 | 189.85 | 134.98 | 144.24 | 37.48 |
Net Cash (Debt) | 689.85 | 655.25 | 574.34 | 542.7 | 510.61 | 499.03 |
Net Cash Growth | 12.14% | 14.09% | 5.83% | 6.28% | 2.32% | 53.36% |
Net Cash Per Share | 3.16 | 3.01 | 2.65 | 2.52 | 2.37 | 2.25 |
Filing Date Shares Outstanding | 218.57 | 217.75 | 216.55 | 216.9 | 214.7 | 245.8 |
Total Common Shares Outstanding | 218.57 | 217.75 | 216.55 | 216.9 | 214.7 | 245.8 |
Working Capital | 654.13 | 603.51 | 529.64 | 509.88 | 483.81 | 479.58 |
Book Value Per Share | 5.09 | 4.70 | 4.60 | 4.80 | 4.71 | 4.29 |
Tangible Book Value | 1,062 | 968.02 | 924.41 | 956.57 | 915.79 | 963.86 |
Tangible Book Value Per Share | 4.86 | 4.45 | 4.27 | 4.41 | 4.27 | 3.92 |
Buildings | - | 192.47 | 192.47 | 192.47 | 205.96 | 209.2 |
Machinery | - | 119.45 | 120.71 | 121.36 | 115.98 | 124.33 |
Construction In Progress | - | 7.96 | 12.06 | 5.71 | 3.39 | 20.96 |